IGF-1, cytokines and biochemical bone turnover markers in synovial fluid and serum of patients with primary and secondary osteoarthritis of the hip;IGF-1, citokini i biokemijski biljezi koštane pregradnje u sinovijalnoj tekuíni i serumu bolesnika s primarnim i sekundarnim osteoartritisom kuka

Biochemia Medica

Volumn 16, Issue 2, 2006, Pages 127-136

  Lis, Kinga ^a   Sypniewska, Grazyna ^a   Nowacki, Wieslaw ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Bone metabolism; IGF 1; Interleukins; Osteoarthritis; Osteonecrosis

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; SOMATOMEDIN C; TRANSCRIPTION FACTOR PAX5;

ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIP OSTEOARTHRITIS; HIP SURGERY; HUMAN; INFLAMMATION; JOINT DEGENERATION; MALE; OSTEOLYSIS; PATHOGENESIS; PREDICTION; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID LEVEL;

EID: 33845887175     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2006.012     Document Type: Article

References (32)

1. Brandt KD. Internal Medicine. Osteoarthritis. Fourth Edition. Mosby-Year Book, Inc 1994:2489
2. Mollenhauer JA, Erdmann S. Introduction: molecular and biomechanical basis of osteoarthritis. Cell Mol Life Sci 2002;59:3-4.
3. Saris DBF, Dhert WJA, Verbout AJ. Joint homeostasis: The discrepancy between old and fresh defects in cartilage repair. J Bone Joint Surg 2003;85-B:1067-76.
4. Henrotin Y, Reginster JY. Anabolic events in osteoarthritis. Osteoarthritis Cartilage 1999;7:370-2.
5. Hunter DJ, Spector TD. The role of bone metabolism in osteoarthritis. Curr Rheumatology Rep 2003;5:15-9.
6. Lajeunesse D. Alterated subchondral osteoblost cellular metabolism in osteoarthritis: cytokines, eicosanoids, and growth factors. J Musculoskel Neuron Interac 2002;2:504-6.
7. Yamamoto T, Yamaguchi T, Lee KB, Bullough PG. A clinicopothologic study of osteonecrosis in osteoarthritic hip. Osteoarthritis Cartilage 2000;8:303-8.
8. Pavelka K. Osteonecrosis. Bailliere's Clin Rheumatology 2000;14:399-414.
9. Tesche F, Miosge N. New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-like chondrocytes in late stages of the disease. Histol Histopothol 2005;20:329-37.
10. Goldberg A. Effects of growth factors on articular cartilage. Ortopedia Traumatologia Rehabilitacja 2001;3:190-3.
11. Martel-Pelletier J, Di Batista JA, Lajeunesse D, Pelletier JR. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 1998;47:90-100.
12. Trippel SB. Growth factor inhibition: potential role in the etiopathogenesis of osteoarthritis. Clin Orthop Relat Res 2004; Suppl 427:47-52.
13. Malemud CJ. Cytokines as therapeutic targets for osteoarthritis. BioDrugs 2004;18:23-35.
14. Denko CW, Malemud CJ. Role of growth hormone/insulin growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheumat 2005;35:24-34.
15. Wang J, Verdonk P, Elewaut D, Veys EM, Verbruggen G. Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro. Osteoarthritis Cartilage 2003;11:801-9.
16. Aigner T, McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci 2002;59:5-18.
17. Sypniewska G, Lis K, Bilinski PJ. Bone turnover markers and cytokines in joint fluid: analyses in 10 patients with loose hip prosthesis and 39 with hip osteoarthritis. Acta Orthop Scand 2002;73:518-22.
18. McAlindon TE, Teale JD, Dieppe PA. Levels of insulin related growth factor 1 in osteoarthritis of the knee. Ann Rheum Dis 1993;52:229-31.
19. Matsumoto T, Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters. Clin Exp Rheumatol 2001;19:655-60.
20. Pagura SM, Thomas SG, Woodhouse LJ, Ezzat S. Women awaiting knee replacement have reduced function of growth hormone. Clin Orthop Relat Res 2003;415:202-13.
21. Pagura SM, Thomas SG, Woodhouse LJ, Ezzat S, Marks P. Circulating and synovial fluid levels of IGF-1, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men. J Orthop Res 2005;23:397-405.
22. Tavera C, Abribat T, Reboul P, Dore S, Brazeau P, Pelletier JP, Martel-Pelletier J. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cartilage 1996;4:263-74.
23. Fernihough JK, Billingham ME, Cwyfan-Huges S, Holly JM. Local disruption of insulin-like growth factor system in the arthritic joint. Arthritis Rheum 1996;39:1556-65.
24. Whellams EJ, Maile LA, Ferninhough JK, Billingharn ME, Holly J.M. Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint. J Endocrinology 2000:165. 545-56.
25. Denko CW, Boja B, Moskowitz RW. Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthritis Cartilage 1996;4:245-9.
26. Hedstrom M, Saaf M, Dalen N. Low IGF-1 levels in hip fracture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients. Acta Orthop Scand 1999;70:145-8.
27. Andersson MK, Stark A, Anissian L, Mohan S, Tsai JA. LowIGF-1 in synovial fluid and serum inpatients with aseptic prosthesis loosening. Acta Orthop 2005;76:320-5.
28. Lis K, Sypniewska G, Bilinski PJ. Interleukin-6, insulin-like growth factor 1 and markers of bone and cartilage destruction in serum and synovial fluid. (abstract) Eur J Clin Invest 2002;32(S2):15.
29. Lis K, Odrowaz-Sypniewska G, Bilinski PJ, Matewski D, Krieger I. Cartilage Oligomeric Matrix Protein (COMP) and glycoprotein YKL-40 as markers of cartilage degradation and inflammation in osteoarthritis. Diagn Lab 2003;39:133-41.
30. Hilal G, Martel-Pelletieri J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheuma 1998;41:891-9.
31. Lajeunesse D, Reboul P. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opinion Rheumatology 2003;15:628-33.
32. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000;6:71-9.